AFC-HD AMS Life Science Co., Ltd.

2927

JP3124700000

Food Processing

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-05-17 am EDT			5-day change	1st Jan Change
862 ^JPY	+1.29%		+0.12%	+7.75%

Apr. 15	Afc-Hd Ams Life Science Co., Ltd. Announces Dividend for the Second Quarter Ended February 2024, Payable on May 17, 2024	CI
2023	Afc-Hd Ams Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending February 2024 and Full Year Ending August 2024	CI

AFC-HD AMS Life Science Co., Ltd. Provides Earnings Guidance for the Period Ending August 2022

April 14, 2022 at 02:30 am EDT

AFC-HD AMS Life Science Co., Ltd. provided earnings guidance for the period ending August 2022. For the period ending August 2022, the company expects consolidated net sales of JPY 22,500 million, operating profit of JPY 1,000 million, profit attributable to owners of parent of JPY 650 million or JPY 46.34 per basic share.

Latest news about AFC-HD AMS Life Science Co., Ltd.

Afc-Hd Ams Life Science Co., Ltd. Announces Dividend for the Second Quarter Ended February 2024, Payable on May 17, 2024	Apr. 15	CI
Afc-Hd Ams Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending February 2024 and Full Year Ending August 2024	23-10-13	CI
Afc-Hd Ams Life Science Co., Ltd. Announces Dividend for Year Ended August 2023, Payable on November 29, 2023; Provides Dividend Guidance for Year Ending August 2024	23-10-13	CI
AFC-HD AMS Life Science Co., Ltd. agreed to acquire Clarize Co., Ltd. from Toshiaki Fujita for ¥1	23-10-01	CI
AFC-HD AMS Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending August 31, 2023	23-07-14	CI
AFC-HD AMS Life Science Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending August 31, 2023	23-07-14	CI
Tranche Update on AFC-HD AMS Life Science Co., Ltd.'s Equity Buyback Plan announced on May 26, 2023.	23-06-27	CI
AFC-HD AMS Life Science Co., Ltd.'s Equity Buyback announced on May 26, 2023, has closed with 100,000 shares, representing 0.71% for Â¥79.57 million.	23-06-26	CI
AFC-HD AMS Life Science Co., Ltd. announces an Equity Buyback for 100,000 shares, representing 0.71% for ¥100 million.	23-05-26	CI
AFC-HD AMS Life Science Co., Ltd. authorizes a Buyback Plan.	23-05-25	CI
AFC-HD AMS Life Science Co., Ltd. Announces Dividend for the Second Quarter Ended Feb. 2023, Payable on May 29, 2023	23-04-14	CI
AFC-HD AMS Life Science Co., Ltd. Provides Earnings Guidance for the Year Ending August 2023	23-04-14	CI
AFC-HD AMS Life Science Co., Ltd. Provides Dividend Guidance for the Year Ending August 2023	23-04-14	CI
AFC-HD AMS Life Science Co., Ltd. Provides Dividend Guidance for the Second Quarter and Full Year of Fiscal 2023	23-01-13	CI
AFC-HD AMS Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Period Ending February 2023 and August 2023	23-01-13	CI
AFC-HD AMS Life Science Co., Ltd. agreed to acquire a 51% stake in 5SPRO Joint Stock Company.	22-12-11	CI
AFC-HD AMS Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Period Ending February 2023 and August 2023	22-10-14	CI
AFC-HD AMS Life Science Co., Ltd. Provides Dividend Guidance for the Second Quarter and Year End of Fiscal 2023	22-10-14	CI
AFC-HD AMS Life Science Co., Ltd. Announces Dividend for the Year End August 2022, Payable on November 30, 2022	22-10-14	CI
AFC-HD AMS Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Period Ending August 31, 2022	22-07-15	CI
AFC-HD AMS Life Science Co., Ltd. Provides Earnings Guidance for the Period Ending August 2022	22-04-14	CI
AFC-HD AMS Life Science Co., Ltd. Announces Dividend for the Second Quarter of 2022, Payable on May 16, 2022	22-04-14	CI
AFC-HD AMS Life Science Co., Ltd. Provides Dividend Guidance for the Year End August 2022	22-04-14	CI
AFC-HD AMS Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending August 2022	22-01-14	CI
AFC-HD AMS Life Science Co., Ltd. Provides Dividend Guidance for the Second Quarter of the Year Ending August 31, 2022	22-01-14	CI

Chart AFC-HD AMS Life Science Co., Ltd.

Duration

Period

More charts

Company Profile

AFC-HD AMS Life Science Co Ltd is a Japan-based company mainly engaged in the development of the healthcare business and the pharmaceutical business. The Company is engaged in the research and development, product design, manufacture and sale of health foods and cosmetics, manufacture and sale of Chinese medicine medicines, general medicines, generic medicines, healthcare products, the sale of natural foods, as well as planning of health information programs. The Company operates in two business segments. The Healthcare segment is engaged in the manufacture and sale of health foods and cosmetics, as well as the provision of original equipment manufacturers (OEM). The Pharmaceutical segment is engaged in the manufacture and sale of ethical drugs and over-the-counter drugs, as well as the sale of generic drugs. The Company is also engaged in the management of restaurants through subsidiary.

Sector

Food Processing

Calendar

2024-07-10 - Q3 2024 Earnings Release (Projected)

More about the company

	1st Jan change	Capi.
AFC-HD AMS LIFE SCIENCE CO., LTD.	+7.75%	76.58M
ZHEJIANG NHU COMPANY LTD.	+16.86%	8.48B
BELLRING BRANDS, INC.	+5.05%	7.6B
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	+4.89%	6.39B
THE SIMPLY GOOD FOODS COMPANY	-5.23%	3.75B
BYHEALTH CO., LTD	-6.58%	3.71B
XIAMEN KINGDOMWAY GROUP COMPANY	-3.55%	1.36B
HERBALIFE LTD.	-28.64%	1.11B
SIRIO PHARMA CO., LTD.	+18.12%	1.02B
USANA HEALTH SCIENCES, INC.	-8.60%	924M

Special Foods & Wellbeing Products